Decision Counseling and Follow-up for Shield+ Patients

Clinical trial NCT07620535 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07620535
Sponsor: Guardant Health, Inc.
Status: NOT_YET_RECRUITING
Study type: OBSERVATIONAL

Colo-rectal Cancer

Start date: 2026-06-01
Primary completion: 2027-12-01
Enrollment: 350

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.